Brief: Clearmind Medicine Announces “Inside MEAI” Webinar Featuring New Insights From CMND-100 Psychedelic Clinical Trial
11/05/2026 13:50
May 11 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE ANNOUNCES “INSIDE MEAI” WEBINAR FEATURING NEW INSIGHTS FROM CMND-100 PSYCHEDELIC CLINICAL TRIAL Source text: ID:nGNX8xztmY Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM